Indian companies filed 184 Type II DMFs with the US FDA in Q1 2026 against China's 149, reinforcing the country's leadership ...

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced its acceptance into the U.S ...

SEATTLE--(BUSINESS WIRE)--Pluristyx, a leading provider of innovative, unmodified, and gene-edited induced pluripotent stem cell (iPSC) lines, submitted a Type II Drug Master File (DMF) to the U.S.

Shoko Co., Ltd. (Head Office: Minato-ku, Tokyo; President & CEO: Kentaro Watanabe; hereinafter “Shoko”), a comprehensive commodity tradin ...

Strategic collaboration at Sanford, North Carolina facility, currently under construction, to optimize cGMP validation, accelerate time-to-market for complex biologics, and shore up U.S. medicine ...

FDA names companies domestic drug manufacturing pilot participants to enhance early regulatory engagement and streamline review processes.

OpenAI has submitted a confidential IPO filing, but the ChatGPT maker says it has not decided on timing or disclosed deal terms. OpenAI has started the formal process that could lead to an initial ...

OpenAI, the company behind ChatGPT, has joined the race between the three tech giants set to list in 2026, each tipped for a landmark initial public offering (IPO). One week after Anthropic filed its ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The Social Security Administration (SSA) denied allegations Friday that ...

SL Science Holding Limited (“SL Science” or the “Company”) (Nasdaq: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced ...

Each year, hundreds of thousands of Americans turn to bankruptcy as a last resort — a legal shield against crushing debt loads that can include high-rate credit card debt, mounting medical bills, or ...